Where does Orthogen AG rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Orthogen AG ranks #49,387 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Orthogen AG hold?

Orthogen AG holds 5 US utility patents granted between 2017 and 2024, spanning 5 technology areas.

What is Orthogen AG's Innovation Score?

Orthogen AG has an Innovation Score of 37.5 out of 100 (top 43% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Orthogen AG's patent grant rate increasing or decreasing?

Orthogen AG's recent grant velocity is +50% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Orthogen AG's patents?

Orthogen AG's patents average 16.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Orthogen AG patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Orthogen AG

Q: What technology areas does Orthogen AG focus on?

Orthogen AG's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 3 patents. Grants appear in 5 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 5 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Orthogen ranks #49,387 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 5 technology areas.

#49,387
of 49,997 US assignees by volume: Top 43%
by Innovation Score (37.5/100): 16.8
avg claims per patent: +50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R49387 · Foreign Corporation #49,387 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #49,387/49,997
PHOTO-FINISH Orient Service
CPC-NARROW A61P · 5 areas
INNOV-THIN 37.5/100
CLAIMS-RICH 16.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Orient Service Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Orthogen · this assignee

38
3D Lighting… · lowest

7

What this shows Orthogen's Innovation Score is 37.5/100 (top 43% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Orthogen's grants concentrate

Orthogen AG is a focused PatentsView assignee: 5 CPC subclasses with 60% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). By volume, Orthogen sits between Orient Service Co., Ltd. and Osco Garden B.V..

Orthogen's three-year grant acceleration

Orthogen AG shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Orient Service

5
Orion Biotech

5
Orion Innovations

5
Orlucent

5
Ortlieb Sportarik…

5
Oryza OIL & FAT C…

5
Osang Healthcare

5
Osco Garden B V

5
Orthogen ◀

5

What this shows Orthogen holds 5 patents at rank #49,310, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Orthogen

By rank, the assignees closest to #49,310 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Orthogen's primary technology class.

Orthogen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

38 Top 43% higher than 57% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Orthogen AG patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	20.0%
2018	1	20.0%
2020	1	20.0%
2023	1	20.0%
2024	1	20.0%

Which technologies does Orthogen AG patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 3

Y02A - Technologies FOR Adaptation TO Climate Change 3

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Top 5 of 5 technology areas

Where it ranks

Overall rank by patents

#49,387

of 49,997 tracked assignees

Innovation Score

37.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Orthogen AG's patent record in context - here's where to go next.

Orthogen AG's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 60% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #49,387 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Orthogen AG against Orient Service Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 37.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.